Intense uptake of In-111 satumomab pendetide in an inflammatory mass, PMID: 8741891
Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates, PMID: 8242578
Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical management, PMID: 8306832
Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer, PMID: 8823804
Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging, PMID: 9755434
Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer, PMID: 7817200
Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis, PMID: 8853918
Diagnostic use of radiolabeled antibodies for cancer, PMID: 8924373
Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature, PMID: 10451876
Monoclonal antibodies in ovarian and prostate cancer, PMID: 8511599
Radiolabeled antibody imaging of patients with potentially resectable colorectal adenocarcinoma, PMID: 8131088
Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma, PMID: 1576351
Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations, PMID: 7750217
[Immunoscintigraphy of prostatic cancer], PMID: 17058687
A practical approach to planar and SPECT imaging of 111In-CYT-103, PMID: 1576346
OncoScint CR103 imaging in the surgical management of patients with colorectal cancer, PMID: 1576352
Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy, PMID: 8790198
Challenges in immunoscintigraphy of ovarian cancer, PMID: 8462895
Site of mistletoe injection observed on In-111 OncoScint imaging, PMID: 9031776
Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody, PMID: 10088160
Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT, PMID: 7724757
The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report, PMID: 8635097
Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice, PMID: 8018538
In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer, PMID: 8508386
Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma, PMID: 12790934
False-positive imaging of In-111 labeled monoclonal antibody conjugate CYT-103 in a patient with metastatic colorectal carcinoma, PMID: 8565379
OncoScint image atlas, PMID: 1576344
Uptake of In-111 GYK-DTPA B72.3 monoclonal antibody in metastatic squamous cell carcinoma, PMID: 7805331
[Indium 111-labeled antibodies in the detection of colorectal carcinoma], PMID: 15307496
Radioimmunodetection of colorectal carcinoma, PMID: 12845972
In-111 CYT-103 immunoscintigraphy of isolated splenic metastasis from ovarian carcinoma, PMID: 9099487
Radiation absorbed dose estimates for indium-111-labeled B72.3, an IgG antibody to ovarian and colorectal cancer: MIRD dose estimate report No. 18, PMID: 9544680
In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: safety, sensitivity, and preliminary clinical results, PMID: 2315476
Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT, PMID: 1523304
Immunoscintigraphy using 111InCyt103 prior to second look laparotomy in ovarian cancer. A pilot study, PMID: 8048395
111In-CYT-103 immunoscintigraphy in ovarian cancer, PMID: 8276314
[Usefulness of scintigraphy images with 111In-CYT-103 in the diagnosis of colonic and rectal recurrence], PMID: 12001423
Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer, PMID: 8418688
Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity, PMID: 7715898
Use of OncoScint scan to assess resectability of hepatic metastases from colorectal cancer, PMID: 11768830
Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients, PMID: 1576345
Oncoscint for detection of disseminated colorectal and ovarian cancer, PMID: 8497207
In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma, PMID: 8319398
Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer, PMID: 8462896
Splenic metastasis from colon carcinoma imaged using In-111 OncoScint, PMID: 7648747
Multicenter clinical trial of 111In-CYT-103 in patients with ovarian cancer, PMID: 1576342
Impact of 111In-CYT-103 on the surgical management of patients with ovarian cancer, PMID: 1576343
Detection of recurrent colorectal carcinoma with In-111 CYT-103 scintigraphy in a patient with nondiagnostic MRI and CT, PMID: 7842571
Immunoscintigraphy of colorectal carcinoma utilizing 111In-labeled monoclonal antibody conjugate CYT-103, PMID: 1879645
Favorable results in cancer imaging and therapy using monoclonal antibodies, PMID: 1837471
For research use only. Not for human or drug use.
